Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis / Ghosh, A. K.; Nyalapatla, R. P.; Kovela, S.; Rao, K. V.; Brindisi, M.; Osswald, H. L.; Amano, M.; Aoki, M.; Agniswamy, J.; Wang, Y. -F.; Weber, I. T.; Mitsuya, H.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 61:10(2018), pp. 4561-4577. [10.1021/acs.jmedchem.8b00298]

Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis

Brindisi M.;
2018

2018
Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis / Ghosh, A. K.; Nyalapatla, R. P.; Kovela, S.; Rao, K. V.; Brindisi, M.; Osswald, H. L.; Amano, M.; Aoki, M.; Agniswamy, J.; Wang, Y. -F.; Weber, I. T.; Mitsuya, H.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 61:10(2018), pp. 4561-4577. [10.1021/acs.jmedchem.8b00298]
File in questo prodotto:
File Dimensione Formato  
acs.jmedchem.8b00298.pdf

non disponibili

Dimensione 3.14 MB
Formato Adobe PDF
3.14 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/771083
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 24
social impact